26 Jan 2023 07:00
Arix Bioscience PLC (ARIX) Board Change 26-Jan-2023 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Arix Bioscience plc Board Change London, 26 January 2023:Β Arix Bioscience plc (βArixβ or the βCompanyβ) (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, today announces Dr Benny Soffer, Non-Executive Director, will step down from the Board on 31 January 2023 in order to spend more time on his other business interests. Peregrine Moncreiffe, Chairman of Arix, commented: βOn behalf of the Board, I would like to thank Benny for the support he has shown to the Company since joining the Board last year and wish him well in his future endeavours.β [ENDS] Β For more information, please contact: Β Arix Bioscience plc +44 (0)20 7290 1050 ir@arixbioscience.com Β Powerscourt Group Sarah MacLeod,Β Ibrahim Khalil, Nick Johnson +44 (0)20 7250 1446 arix@powerscourt-group.com Β Β About Arix Bioscience plc Β Arix Bioscience plc is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting-edge advances in life sciences. Β We collaborate with exceptional entrepreneurs and provide the capital, expertise, and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com Β |
| ISIN: | GB00BD045071 |
| Category Code: | BOA |
| TIDM: | ARIX |
| LEI Code: | 213800OVT3AHQCXNIX43 |
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
| Sequence No.: | 218423 |
| EQS News ID: | 1543761 |
| Β | |
| End of Announcement | EQS News Service |
UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.
Follow the stocks